Chr. Hansen delivers a solid financial result of 9 % organic growth for the first nine months of 2018/19, but adjusts full-year organic growth outlook from 9 to 11 % to 7 to 8 %. Food Cultures & Enzymes grew by 9 %, Health & Nutrition by 11 % and Natural Colours by 4 %. Currencies impacted Euro growth negatively by 2 %. Ebit before special items increased by 10 % to EUR 241 m, corresponding to an Ebit margin before special items of 28.2 %, up 0.7 %-point compared to last year. In Q3, organic growth was 8 %, and Ebit before special items increased by 9 %. Organic growth outlook for 2018/19 is adjusted to 7 to 8%, whereas the guidance on EBIT is unchanged and the guidance on FCF is adjusted upwards.

CEO Mauricio Graber says: “We delivered a solid Q3 result despite more challenging trading conditions, mainly in emerging markets. Performance in Food Cultures & Enzymes continues to be in line with expectations, and we are progressing well on our strategic agenda of delivering new innovative solutions to customers, so we can continue to grow solidly and profitably, even in markets with lower volume growth momentum.”